Edward Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Edward Yang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amit G. Singal
Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA
1 shared publication - Darine Daher
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA
1 shared publication - David T. Fetzer
Department of Radiology, University of Texas Southwestern Medical Center, Dallas, USA
1 shared publication - Karim Seif El Dahan
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA
1 shared publication - Matthew S. Davenport
Departments of Radiology and Urology, Michigan Medicine, Ann Arbor, Mich
1 shared publication - Mishal Mendiratta-Lala
Department of Radiology, University of Michigan, Ann Arbor, Mich
1 shared publication
Latest Publications
- 15 November 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (5) , 2097-2109
Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection
Purpose MRI is a potential alternative to ultrasound for hepatocellular carcinoma (HCC) detection. We evaluated the impact of ultrasound and dynamic abbreviated MRI (AMRI) exam quality on early-stage HCC detection. Methods We conducted a multicenter case-control study among patients with cirrhosis (cases with early-stage HCC per Milan Criteria; controls without HCC) who underwent both a liver ultrasound and dynamic contrast-enhanced (DCE) AMRI within 6 months in 2012–2019. Two radiologists performed independent, blinded interpretations of both exams for HCC detection and scored exam quality as no/mild, moderate, or severe limitations. Associations between exam quality, patient characteristics, and HCC detection were assessed by odds ratios (OR). Results Of 216 cases and 432 controls, severe limitations were reported in 7% and 8% of ultrasounds and DCE-AMRIs, respectively. Severe limitations at ultrasound were associated with obesity (OR 2.08, 95%CI [1.32–3.32]) and metabolic dysfunction-associated steatotic liver disease (MASLD) (OR 1.98 [1.12–3.44]) but not for DCE-AMRI. Decompensated cirrhosis (Child-Pugh C) was associated with severe limitations for both ultrasound (OR 2.54 [1.37–4.58]) and DCE-AMRI (OR 3.96 [2.36–6.58]). Compared to exams with no/mild limitations, exams with severe limitations had lower sensitivity for ultrasound (79.6% vs. 21.7%, P < 0.001) and AMRI (86.1% vs. 50.0%, P = 0.001). In patients in whom ultrasound was severely limited, DCE-AMRI had significantly higher odds of early-stage HCC detection than ultrasound (OR 8.23 [1.25–54.02]). Conclusions HCC detection by DCE-AMRI may be preferred in patients with severe limitations at ultrasound due to obesity and MASLD. Both modalities remain limited for patients with decompensated cirrhosis, for whom alternative strategies may be needed.
- 15 November 2024
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (5) , 2097-2109
Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection
Purpose MRI is a potential alternative to ultrasound for hepatocellular carcinoma (HCC) detection. We evaluated the impact of ultrasound and dynamic abbreviated MRI (AMRI) exam quality on early-stage HCC detection. Methods We conducted a multicenter case-control study among patients with cirrhosis (cases with early-stage HCC per Milan Criteria; controls without HCC) who underwent both a liver ultrasound and dynamic contrast-enhanced (DCE) AMRI within 6 months in 2012–2019. Two radiologists performed independent, blinded interpretations of both exams for HCC detection and scored exam quality as no/mild, moderate, or severe limitations. Associations between exam quality, patient characteristics, and HCC detection were assessed by odds ratios (OR). Results Of 216 cases and 432 controls, severe limitations were reported in 7% and 8% of ultrasounds and DCE-AMRIs, respectively. Severe limitations at ultrasound were associated with obesity (OR 2.08, 95%CI [1.32–3.32]) and metabolic dysfunction-associated steatotic liver disease (MASLD) (OR 1.98 [1.12–3.44]) but not for DCE-AMRI. Decompensated cirrhosis (Child-Pugh C) was associated with severe limitations for both ultrasound (OR 2.54 [1.37–4.58]) and DCE-AMRI (OR 3.96 [2.36–6.58]). Compared to exams with no/mild limitations, exams with severe limitations had lower sensitivity for ultrasound (79.6% vs. 21.7%, P < 0.001) and AMRI (86.1% vs. 50.0%, P = 0.001). In patients in whom ultrasound was severely limited, DCE-AMRI had significantly higher odds of early-stage HCC detection than ultrasound (OR 8.23 [1.25–54.02]). Conclusions HCC detection by DCE-AMRI may be preferred in patients with severe limitations at ultrasound due to obesity and MASLD. Both modalities remain limited for patients with decompensated cirrhosis, for whom alternative strategies may be needed.